Notably, XIAP is associated with activation of the inflammatory response, which in turn negatively regulates the expression of NLRP3 inflammasomes and ultimately relieves the effects of NAFLD. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.